Variable | HR | 95.0% confidence interval | P value | |
---|---|---|---|---|
Lower | Upper | |||
Sex (female vs. male) | 1.265 | 0.701 | 2.284 | 0.435 |
Age (<60 y vs. ≥ 60y) | 0.953 | 0.552 | 1.646 | 0.864 |
Karnofsky performance status (≤80 vs. >80) | 0.779 | 0.425 | 1.428 | 0.420 |
Pathological type (Squamous vs.Non-Squamous ) | 1.314 | 0.785 | 2.199 | 0.298 |
Tumor volume (per cm3 incerase) | 1.002 | 1.000 | 1.003 | 0.054 |
T stage (T3-4 vs.T1-2) | 1.209 | 0.677 | 2.157 | 0.521 |
N stage (N2-3 vs.N0-1) | 1.015 | 0.435 | 2.366 | 0.973 |
Metastasis status (multi- vs. single) | 1.765 | 1.032 | 3.018 | 0.038 |
Thoracic radiation dose (≥63 Gy vs. <63 Gy) | 0.547 | 0.333 | 0.897 | 0.017 |
Response of primary tumor (SD + PD vs. CR + PR) | 1.232 | 0.574 | 2.642 | 0.592 |
Radiotherapy to metastases (yes vs. no) | 0.890 | 0.511 | 1.551 | 0.681 |